Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 92941V407 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
Bellevue Group AG
13G
|
10.6% |
10/7/2026
Event 9/10/2026
|
|
| Bellevue Group AG | 10.6% | ||
| Bellevue Asset Management AG | 10.6% | ||
|
Invus Global Management, LLC
13G
|
7.2% |
9/17/2026
Event 9/11/2026
|
|
| Invus Public Equities, L.P. | 6.3% | ||
| Invus Public Equities Advisors, LLC | 6.3% | ||
| Invus Global Management, LLC | 6.3% | ||
| Siren, L.L.C. | 6.3% | ||
| Avicenna Life Sci Master Fund LP | 0.9% | ||
| Avicenna Life Sci Master GP LLC | 0.9% | ||
| Ulys, L.L.C. | 0.9% | ||
| Raymond Debbane | 7.2% | ||
|
ADAR1 Capital Management, LLC
13G
|
8.8% |
8/14/2026
Event 6/30/2026
|
|
| ADAR1 Capital Management, LLC | 8.8% | ||
| Daniel Schneeberger | 8.8% | ||
|
venBio Global Strategic Fund V, L.P.
13G
|
10.0% |
8/14/2026
Event 7/27/2026
|
|
| venBio Global Strategic Fund V, L.P. | 10.0% | ||
| venBio Global Strategic GP V, LLC | 10.0% | ||
| Zhang Xiaofan 13G/A Amendment 3 | 0.6% |
8/13/2026
Event 8/13/2026
|
|
| Janus Henderson Group Ltd. 13G | 10.0% |
8/7/2026
Event 7/31/2026
|
|
|
Logos Global Management LP
13G/A
Amendment 1
|
10.7% |
8/7/2026
Event 7/31/2026
|
|
| Logos Global Management LP | 10.7% | ||
| Logos Global Management GP LLC | 10.7% | ||
| Logos Global Master Fund LP | 6.6% | ||
| Logos GP LLC | 6.6% | ||
| Logos Opportunities Fund V LP | 4.1% | ||
| Logos Opportunities V GP LLC | 4.1% | ||
| Arsani William | 10.7% | ||
| Graham Walmsley | 4.1% | ||
|
Orbimed Advisors LLC
13D
|
10.0% |
8/5/2026
Event 7/27/2026
|
|
| Orbimed Advisors LLC | 10.0% | ||
| OrbiMed Capital GP X LLC | 8.7% | ||
| OrbiMed Capital GP X, LP | 8.7% | ||
| OrbiMed Genesis GP LLC | 1.3% | ||
|
Logos Global Management LP
13G
|
9.9% |
8/4/2026
Event 7/27/2026
|
|
| Logos Global Management LP | 9.9% | ||
| Logos Global Management GP LLC | 9.9% | ||
| Logos Global Master Fund LP | 9.9% | ||
| Logos GP LLC | 9.9% | ||
| Logos Opportunities Fund V LP | 9.9% | ||
| Logos Opportunities V GP LLC | 9.9% | ||
| Arsani William | 9.9% | ||
| Graham Walmsley | 9.9% | ||
|
Perceptive Advisors LLC
13G
|
10.0% |
8/3/2026
Event 7/27/2026
|
|
| Perceptive Advisors LLC | 10.0% | ||
| Joseph Edelman | 10.0% | ||
| Perceptive Life Sciences Master Fund, Ltd. | 10.0% | ||
|
RTW Fund Group GP, LLC
13G
|
10.0% |
7/30/2026
Event 7/27/2026
|
|
| RTW Fund Group GP, LLC | 10.0% | ||
| Roderick Wong | 10.0% | ||
|
AI Biotechnology LLC
13D/A
Amendment 1
|
6.0% |
7/29/2026
Event 7/27/2026
|
|
| AI Biotechnology LLC | 6.0% | ||
| Access Industries Holdings LLC | 6.0% | ||
| Access Industries Management, LLC | 6.0% | ||
| Len Blavatnik | 6.0% |
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|